Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure-Reference-Cited by-同舟云学术

Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure

Published:2020-06 Issue:6 Volume:8 Page:489-498
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Prasada Sameer,Rivera Adovich,Nishtala Arvind,Pawlowski Anna E.,Sinha Arjun,Bundy Joshua D.,Chadha Simran A.,Ahmad Faraz S.,Khan Sadiya S.,Achenbach Chad,Palella Frank J.,Ramsey-Goldman Rosalind,Lee Yvonne C.,Silverberg Jonathan I.,Taiwo Babafemi O.,Shah Sanjiv J.,Lloyd-Jones Donald M.,Feinstein Matthew J.

Funder

Office of Extramural Research, National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference62 articles.

1. The link between inflammatory disorders and coronary heart disease: a look at recent studies and novel drugs in development;Teague;Curr Atheroscler Rep,2016

2. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus;Esdaile;Arthritis Rheum,2001

3. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study;Dregan;Circulation,2014

4. Chronic inflammatory diseases and cardiovascular risk: a systematic review;Roifman;Can J Cardiol,2011

5. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies;Avina-Zubieta;Ann Rheum Dis,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis;PLOS ONE;2024-06-14

2. Human immunology of heart failure: deconstructing inflammatory risk;European Heart Journal;2024-05-21

3. Risk of heart failure in inflammatory bowel disease: a Swedish population-based study;European Heart Journal;2024-05-21

4. Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study;RMD Open;2024-04

5. Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis;Archives of Rheumatology;2024-01-29